NYSE - Delayed Quote • USD
Boston Scientific Corporation (BSX)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 7:51 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 26 | 26 | 32 | 31 |
| Avg. Estimate | 0.58 | 0.57 | 2.32 | 2.63 |
| Low Estimate | 0.57 | 0.55 | 2.25 | 2.54 |
| High Estimate | 0.59 | 0.59 | 2.35 | 2.76 |
| Year Ago EPS | 0.53 | 0.5 | 2.05 | 2.32 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 23 | 23 | 31 | 30 |
| Avg. Estimate | 4.01B | 3.95B | 15.94B | 17.52B |
| Low Estimate | 3.86B | 3.9B | 15.52B | 16.95B |
| High Estimate | 4.04B | 4.05B | 16.2B | 18.08B |
| Year Ago Sales | 3.6B | 3.53B | 14.24B | 15.94B |
| Sales Growth (year/est) | 11.40% | 12.00% | 11.90% | 10.00% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 0.49 | 0.48 | 0.51 | 0.51 |
| EPS Actual | 0.53 | 0.5 | 0.55 | 0.56 |
| Difference | 0.04 | 0.02 | 0.04 | 0.05 |
| Surprise % | 8.20% | 4.20% | 7.80% | 9.80% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.58 | 0.57 | 2.32 | 2.63 |
| 7 Days Ago | 0.56 | 0.56 | 2.25 | 2.55 |
| 30 Days Ago | 0.56 | 0.56 | 2.25 | 2.55 |
| 60 Days Ago | 0.56 | 0.56 | 2.25 | 2.55 |
| 90 Days Ago | 0.57 | 0.56 | 2.24 | 2.53 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 21 | 16 | 27 | 27 |
| Up Last 30 Days | 22 | 16 | 28 | 28 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | 3 | -- | -- |
Growth Estimates
| CURRENCY IN USD | BSX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 9.40% | -- | -- | 6.50% |
| Next Qtr. | 14.00% | -- | -- | 12.00% |
| Current Year | 13.20% | -- | -- | 5.30% |
| Next Year | 13.40% | -- | -- | 13.10% |
| Next 5 Years (per annum) | 12.40% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 14.29% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Barclays: Overweight to Overweight | 4/26/2024 |
| Maintains | Citigroup: Buy to Buy | 4/25/2024 |
| Maintains | Deutsche Bank: Hold to Hold | 4/25/2024 |
| Maintains | JP Morgan: Overweight to Overweight | 4/25/2024 |
| Maintains | RBC Capital: Outperform to Outperform | 4/25/2024 |
| Maintains | Raymond James: Strong Buy to Strong Buy | 4/25/2024 |
Related Tickers
ALGN Align Technology, Inc.
309.02
-0.48%
MDT Medtronic plc
79.74
+0.62%
DXCM DexCom, Inc.
124.34
-9.91%
EW Edwards Lifesciences Corporation
86.43
-1.80%
ABT Abbott Laboratories
107.53
+0.63%
SYK Stryker Corporation
335.61
-0.46%
SWAV Shockwave Medical, Inc.
330.00
+0.31%
INSP Inspire Medical Systems, Inc.
237.45
+2.79%
TMDX TransMedics Group, Inc.
92.08
+3.17%
NARI Inari Medical, Inc.
38.42
+0.92%